Growth versus value has long been a key debate in the investing community. And the latest developments at Palantir and SMCI have made them a fitting pair for such comparison. Although both stocks were once viewed jointly as key AI beneficiaries, they've since diverged in their paths. On one hand, Palantir's soaring to all-time highs with an eyewatering valuation of almost 50x NTM sales, backed by AI-driven acceleration to its growth trajectory. Meanwhile, on the other hand, whether SMCI's fall from grace can be reverted remains a substantial uncertainty, given ongoing accounting woes and their implications. The following analysis will discuss the context of both stock's performance this year, and provide a deep dive into their growth and value implications ahead. hapabapa There’s long been